NCT05420038 is a clinical trial in Hearing Impairment, sponsored by The University of Texas Medical Branch, Galveston.

Who is sponsoring NCT05420038?

NCT05420038 is sponsored by The University of Texas Medical Branch, Galveston.

What condition does NCT05420038 study?

NCT05420038 studies Hearing Impairment.

Is NCT05420038 still recruiting?

NCT05420038 is currently completed. Last updated 9 June 2023.

Last reviewed 2023-06-09 · How we verify

NCT05420038

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Do Bluetooth Noise Cancelling Headphones Improve the Quality of Care in Hearing Impaired Patients?

Completed Last updated 9 June 2023

What this trial tests

trial in Hearing Impairment in 30 participants. Completed in 19 April 2023.

Timeline

6 July 2022

Primary endpoint
19 April 2023

19 April 2023

Quick facts

Lead sponsor	The University of Texas Medical Branch, Galveston
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	6 July 2022
Primary completion	19 April 2023
Estimated completion	19 April 2023
Sites	1 location across United States

Conditions studied

Hearing Impairment — all drugs for Hearing Impairment →

Sponsor

The University of Texas Medical Branch, Galveston

Who can join

55 and older, any sex, with Hearing Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will be recruited by performing chart reviews of patients to be seen at University of Texas Medical Branch at Galveston Ophthalmology and Optometry Clinic. A sample size of at least 30 patients is needed (60 eyes). Patients aged 55 and higher will be further evaluated to meet the inclusion criteria. Patients meeting inclusion criteria will be provided with informed consent to participate in the study before their office visit. Patients will receive a consent briefing then asked to sign and date the informed consent form. Participants will then be randomized to undergo an eye exam and refractive exam with noise cancelling Bluetooth headphones for one eye and without for the other eye. Participants will fill out a written survey asking them to rate the quality of the eye exam with and without headphones. Primary aim: Assess the quality improvement of Ophthalmic exam in geriatric patients with hearing loss with use of noise cancelling headphones with Bluetooth feature. Secondary aims: 1)Compare the response to the standardized questions with and without Bluetooth noise cancelling headphones to determine their effectiveness in conducting Ophthalmic refractive exam. 2\) Explore the ease of conducting refractive exam as reported by provider.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bluetooth Noise-Canceling Headphones Improve the Quality of Ophthalmic Exams in Patients With Hearing Loss: A Randomized Controlled Trial.
Glanzer BM, Ladki M, Chea MR, Hummel L, et al · · 2024 · cited 1× · PMID 38860057 · DOI 10.7759/cureus.60090

Verify or expand the search:

Other recruiting trials for Hearing Impairment

Currently open trials in the same condition.

NCT06663917 — Clinical Evaluation of Frequency Allocation for Bimodal CI Users · NA · recruiting
NCT06680934 — CABP2 Patient Registry and Natural History Study · recruiting
NCT05847426 — Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS) · NA · recruiting
NCT05805384 — Evaluating a Noise Reduction Algorithm With Cochlear Implant Users · NA · recruiting
NCT05946057 — Otoferlin Patient Registry and Natural History Study · recruiting

Other The University of Texas Medical Branch, Galveston trials

Trials by the same sponsor.

NCT04095260 — Identification of Neuromusculoskeletal Variables Associated With Injury Risk and Performance in High School Athletes. · not yet recruiting
NCT06800092 — Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment · Phase 2, PHASE3 · not yet recruiting
NCT07337915 — Improving Sleep In Midlife Women · NA · recruiting
NCT07203287 — Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease · Phase 4 · recruiting
NCT07087743 — Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05420038 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Medical Branch, Galveston
Last refreshed: 9 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing